Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Kura Oncology
KURA
$711M
| $892K | ﹤0.01% |
64,900
+3,500
| +6% | +$48.1K |
|
2202
PDF Solutions
PDFS
$765M
| $892K | ﹤0.01% |
52,800
+1,700
| +3% | +$28.7K |
|
2203
Expro
XPRO
$1.43B
| $892K | ﹤0.01% |
28,750
+900
| +3% | +$27.9K |
|
|
STML
2204
DELISTED
Stemline Therapeutics, Inc.
STML
| $891K | ﹤0.01% |
83,800
+1,200
| +1% | +$12.8K |
|
2205
Forrester Research
FORR
$195M
| $890K | ﹤0.01% |
21,350
+1,000
| +5% | +$41.7K |
|
|
GSKY
2206
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $889K | ﹤0.01% |
99,900
| – | – |
|
2207
Astrana Health
ASTH
$1.38B
| $886K | ﹤0.01% |
48,144
+1,500
| +3% | +$27.6K |
|
2208
REX American Resources
REX
$1.01B
| $885K | ﹤0.01% |
32,400
+600
| +2% | +$16.4K |
|
2209
United Natural Foods
UNFI
$1.77B
| $884K | ﹤0.01% |
100,900
+5,400
| +6% | +$47.3K |
|
2210
National CineMedia
NCMI
$455M
| $882K | ﹤0.01% |
12,100
+400
| +3% | +$29.2K |
|
2211
Repay Holdings
RPAY
$507M
| $882K | ﹤0.01% |
+60,200
| New | +$882K |
|
2212
Team
TISI
$81.8M
| $881K | ﹤0.01% |
5,516
+200
| +4% | +$31.9K |
|
|
AXNX
2213
DELISTED
Axonics, Inc. Common Stock
AXNX
| $881K | ﹤0.01% |
31,800
+13,200
| +71% | +$366K |
|
2214
Independent Bank Corp
IBCP
$657M
| $879K | ﹤0.01% |
38,800
-700
| -2% | -$15.9K |
|
2215
Diamond Hill
DHIL
$387M
| $878K | ﹤0.01% |
6,254
| – | – |
|
|
GPOR
2216
DELISTED
Gulfport Energy Corp.
GPOR
| $876K | ﹤0.01% |
288,058
| – | – |
|
|
HTB
2217
HomeTrust Bancshares, Inc.
HTB
$713M
| $867K | ﹤0.01% |
32,300
| – | – |
|
|
OMN
2218
DELISTED
OMNOVA Solutions Inc.
OMN
| $867K | ﹤0.01% |
85,800
+1,600
| +2% | +$16.2K |
|
2219
Equity Bancshares
EQBK
$800M
| $862K | ﹤0.01% |
27,932
| – | – |
|
2220
Regis Corp
RGS
$70.8M
| $861K | ﹤0.01% |
2,410
-210
| -8% | -$75K |
|
|
GTS
2221
DELISTED
Triple-S Management Corporation
GTS
| $861K | ﹤0.01% |
46,564
+3,000
| +7% | +$55.5K |
|
|
CHS
2222
DELISTED
Chicos FAS, Inc.
CHS
| $860K | ﹤0.01% |
225,600
+4,300
| +2% | +$16.4K |
|
2223
Kimball Electronics
KE
$741M
| $855K | ﹤0.01% |
48,700
+800
| +2% | +$14K |
|
|
HAYN
2224
DELISTED
Haynes International, Inc.
HAYN
| $855K | ﹤0.01% |
23,900
+600
| +3% | +$21.5K |
|
2225
Lindblad Expeditions
LIND
$735M
| $854K | ﹤0.01% |
52,241
+5,400
| +12% | +$88.3K |
|